Answer
Trelegy Ellipta is contraindicated in patients with hypersensitivity to its active substances or any excipient listed in section 6.1 of its product information.
Sources for this answer
- Trelegy Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensedGlaxoSmithKline UK · emc · SmPC §4.3 Contraindications · Version 12Document updated
Sources checked